Log In
Print
BCIQ
Print
Print this Print this
 

Mydicar (AAV1/SERCA2a)

  Manage Alerts
Collapse Summary General Information
Company Celladon Corp.
DescriptionRecombinant adeno-associated viral (AAV) vector bearing the sarcoplasmic reticulum SERCA2A gene
Molecular Target ATPase Ca++ transporting cardiac muscle slow twitch 2 (ATP2A2) (SERCA2A)
Mechanism of ActionGene therapy
Latest Stage of DevelopmentPhase II
IndicationHeart failure
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today